GENUV INC has a total of 16 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2017. It filed its patents most often in Republic of Korea, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are AXIOGENESIS AG, ISTITUTO NAZ DI GENETICA MOLEC and NEURO THERAPEUTICS AB.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | United States | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Chile | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Mexico | 1 | |
#10 | Philippines | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials | |
#4 | Microorganisms | |
#5 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Han Sungho | 12 |
#2 | Kim Mi-Yeon | 9 |
#3 | Choi Kang-Yell | 8 |
#4 | Kim Mi Yeon | 2 |
#5 | Kang- Yell Choi | 1 |
#6 | Mi-Yeon Kim | 1 |
#7 | Mi- Yeon Kim | 1 |
#8 | Hong Tae Joon | 1 |
#9 | Han Sung Ho | 1 |
#10 | Lee Sun-Young | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020235954A1 | Administration method and dosage regimen for treatment of neurodegenerative diseases using trametinib and markers | |
US2020368239A1 | Treatment of amyotrophic lateral sclerosis using trametinib | |
KR20190125940A | Drug-containing plga microspheres and the preparation methods thereof | |
EP3800471A1 | Composition for promoting differentiation of and protecting neural stem cells and method for inducing neural regeneration using same | |
KR20190056758A | Combination therapy for treating cancers characterized by having cancer stem cells |